Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ronald Preblick

Showing results (1-10 of 33) with videos related to

Pageof 4
Sort By:
Journal of Managed Care & Specialty Pharmacy|August 29, 2020
Limited Generalizability of a Retrospective Chart Review Comparing 3 Recombinant FVIII Products for Hemophilia A ProphylaxisRonald Preblick, Cori Gray, Talaha Ali, et al.
Journal of Managed Care Pharmacy : JMCP|April 5, 2007
Effects of a step-therapy program for angiotensin receptor blockers on antihypertensive medication utilization patterns and cost of drug therapyKrista Yokoyama, Winnie Yang, Ronald Preblick, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 27, 2013
Fatigue heralding multiple sclerosisJoseph R Berger, Jennifer Pocoski, Ronald Preblick, et al.
American Health & Drug Benefits|January 6, 2015
Utilization of parenteral anticoagulants and warfarin: impact on the risk of venous thromboembolism recurrence in the outpatient settingJennifer Cai, Ronald Preblick, Qiaoyi Zhang, et al.
Hospital Practice (1995)|November 10, 2015
Cost-effectiveness of edoxaban for the treatment of venous thromboembolism based on the Hokusai-VTE studyRonald Preblick, W Jacqueline Kwong, Richard H White, et al.
Clinicoeconomics and Outcomes Research : CEOR|September 11, 2015
Review of the cost of venous thromboembolismMaria M Fernandez, Susan Hogue, Ronald Preblick, et al.
Congestive Heart Failure (Greenwich, Conn.)|July 25, 2009
Effects of angiotensin-converting enzyme inhibitor or angiotensin receptor blocker therapy after hospital discharge on subsequent rehospitalization for acute myocardial infarction and heart failureGregory Hess, Ronald Preblick, Jerrold Hill, et al.
Journal of Medical Economics|August 19, 2025
Economic value of intra-articular knee OA therapies: a U.S. perspectiveVinod Dasa, Wilson Ngai, Kevin Steele, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|January 30, 2015
Economic burden of recurrent venous thromboembolism: analysis from a U.S. hospital perspectiveJulian P Casciano, Zenobia Dotiwala, Robert Kemp, et al.
Hospital Practice (1995)|December 16, 2014
Treatment patterns and outcomes among hospitalized patients with venous thromboembolism in the United States: an analysis of electronic health records dataJoseph Menzin, Ronald Preblick, Mark Friedman, et al.
Pageof 4

Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
Journal of Managed Care & Specialty Pharmacy|August 29, 2020
Limited Generalizability of a Retrospective Chart Review Comparing 3 Recombinant FVIII Products for Hemophilia A ProphylaxisRonald Preblick, Cori Gray, Talaha Ali, et al.
Journal of Managed Care Pharmacy : JMCP|April 5, 2007
Effects of a step-therapy program for angiotensin receptor blockers on antihypertensive medication utilization patterns and cost of drug therapyKrista Yokoyama, Winnie Yang, Ronald Preblick, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 27, 2013
Fatigue heralding multiple sclerosisJoseph R Berger, Jennifer Pocoski, Ronald Preblick, et al.
American Health & Drug Benefits|January 6, 2015
Utilization of parenteral anticoagulants and warfarin: impact on the risk of venous thromboembolism recurrence in the outpatient settingJennifer Cai, Ronald Preblick, Qiaoyi Zhang, et al.
Hospital Practice (1995)|November 10, 2015
Cost-effectiveness of edoxaban for the treatment of venous thromboembolism based on the Hokusai-VTE studyRonald Preblick, W Jacqueline Kwong, Richard H White, et al.
Clinicoeconomics and Outcomes Research : CEOR|September 11, 2015
Review of the cost of venous thromboembolismMaria M Fernandez, Susan Hogue, Ronald Preblick, et al.
Congestive Heart Failure (Greenwich, Conn.)|July 25, 2009
Effects of angiotensin-converting enzyme inhibitor or angiotensin receptor blocker therapy after hospital discharge on subsequent rehospitalization for acute myocardial infarction and heart failureGregory Hess, Ronald Preblick, Jerrold Hill, et al.
Journal of Medical Economics|August 19, 2025
Economic value of intra-articular knee OA therapies: a U.S. perspectiveVinod Dasa, Wilson Ngai, Kevin Steele, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|January 30, 2015
Economic burden of recurrent venous thromboembolism: analysis from a U.S. hospital perspectiveJulian P Casciano, Zenobia Dotiwala, Robert Kemp, et al.
Hospital Practice (1995)|December 16, 2014
Treatment patterns and outcomes among hospitalized patients with venous thromboembolism in the United States: an analysis of electronic health records dataJoseph Menzin, Ronald Preblick, Mark Friedman, et al.
Pageof 4